SF
GMED icon

Synovus Financial’s Globus Medical GMED Stock Holding History

Synovus Financial’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.24M Sell
21,676
-183
-0.8% -$10.5K 0.01% 470
2025
Q2 		$1.29M Sell
21,859
-2,894
-12% -$187K 0.02% 444
2025
Q1 		$1.81M Buy
24,753
+10,209
+70% +$844K 0.02% 368
2024
Q4 		$1.2M Buy
14,544
+233
+2% +$18.4K 0.02% 445
2024
Q3 		$1.02M Buy
14,311
+1,281
+10% +$90.4K 0.01% 503
2024
Q2 		$892K Buy
13,030
+566
+5% +$33.8K 0.01% 480
2024
Q1 		$669K Sell
12,464
-19
-0.2% -$1.02K 0.01% 558
2023
Q4 		$665K Buy
12,483
+37
+0.3% +$1.8K 0.01% 531
2023
Q3 		$618K Buy
12,446
+1,962
+19% +$110K 0.01% 556
2023
Q2 		$624K Sell
10,484
-415
-4% -$23.7K 0.01% 551
2023
Q1 		$617K Sell
10,899
-3,376
-24% -$216K 0.01% 559
2022
Q4 		$1.06M Buy
14,275
+415
+3% +$28.3K 0.01% 446
2022
Q3 		$825K Buy
13,860
+1,589
+13% +$95.7K 0.01% 466
2022
Q2 		$688K Buy
12,271
+250
+2% +$16.4K 0.01% 498
2022
Q1 		$889K Buy
12,021
+36
+0.3% +$2.5K 0.01% 463
2021
Q4 		$870K Buy
11,985
+2,211
+23% +$161K 0.01% 494
2021
Q3 		$754K Buy
9,774
+495
+5% +$39.7K 0.01% 505
2021
Q2 		$720K Sell
9,279
-3,390
-27% -$241K 0.01% 518
2021
Q1 		$784K Buy
12,669
+562
+5% +$35.6K 0.01% 452
2020
Q4 		$795K Buy
12,107
+50
+0.4% +$2.87K 0.01% 427
2020
Q3 		$597K Buy
12,057
+1,762
+17% +$90.9K 0.01% 451
2020
Q2 		$492K Buy
10,295
+194
+2% +$9.36K 0.01% 463
2020
Q1 		$430K Buy
10,101
+1,807
+22% +$89.3K 0.01% 555
2019
Q4 		$496K Buy
8,294
+294
+4% +$16K 0.01% 467
2019
Q3 		$412K Buy
+8,000
New +$381K 0.01% 502
2018
Q3 		– Sell
-15
Closed -$1K – 1398
2018
Q2 		$1K Buy
+15
New +$782 ﹤0.01% 1217

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Synovus Financial's GMED Position: Q3 2025 in Review

Synovus Financial reduced its Globus Medical (GMED) stake by 0.84% in Q3 2025, selling an estimated $10.5K and leaving 21,676 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #470.

Synovus Financial first reported a position in GMED in Q2 2018 and has held it in 26 quarters since. The position peaked at $1.81M in Q1 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Synovus Financial held 21,676 shares of Globus Medical worth $1.24M as of Q3 2025.
  • Synovus Financial sold 183 Globus Medical shares in Q3 2025, an estimated $10.5K.
  • Globus Medical made up 0.01% of Synovus Financial's portfolio in Q3 2025, its #470 holding.
  • Synovus Financial first reported a position in Globus Medical in Q2 2018 and has held it in 26 quarters since.
  • Synovus Financial's Globus Medical position peaked at $1.81M in Q1 2025.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.